Veraxa Biotech Holding AG 20-F annual reports
The annual report filed by foreign private issuers listed on a US exchange — the 10-K’s equivalent for non-US companies.
NASDAQ
Veraxa Biotech AG announces the completion of its business combination with Voyager Acquisition Corp., effective June 10, 2026, alongside significant financing updates.